Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TXN
3. NOW
4. TSLA
5. CSX
6. GOOG
7. IBM
8. KNX
9. LVS
10. INTC

Go back to Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy
(NASDAQ: AXSM) Delayed: 241.04 +1.42 (0.59%)
Previous Close $239.62    52 Week High $15.74 
Open $239.00    52 Week Low $5.37 
Day High $241.04    P/E N/A 
Day Low $237.00    EPS $0.00 
Volume 46,917